Xuying He1, Chuanzhi Duan2, Lingfeng Lai2, Xin Zhang2, Zhenjun Li2, Xifeng Li2, Tielin Li2. 1. Department of Neurosurgery, Zhujiang Hospital of Southern Medical University, National clinical key subject, Guangdong Provincial Clinical Medical Centre Department of Neurosurgery, Guangzhou, 510282, China. 2517079319@qq.com. 2. Department of Neurosurgery, Zhujiang Hospital of Southern Medical University, National clinical key subject, Guangdong Provincial Clinical Medical Centre Department of Neurosurgery, Guangzhou, 510282, China.
Abstract
OBJECTIVES: To characterise the safety, efficacy and cost of direct carotid-cavernous fistula (CCF) treatment using polyvinyl alcohol copolymer or detachable balloons. METHODS: We reviewed retrospectively patients with direct CCFs treated with either a detachable balloon or polyvinyl alcohol copolymer at our hospital from 2005 to 2015 and identified 94 patients with 105 CCFs. All patients had follow-up angiograms. The CCF occlusion rate, procedure complication rate, treatment expense and operation time were recorded. RESULTS: With a mean of 5.4 months of angiographic follow-up, the complete occlusion rate and recanalisation rate of the polyvinyl alcohol copolymer group was not significantly different from that of the detachable balloon group. The treatment expense was much higher and the operation time was much longer in the polyvinyl alcohol copolymer group than the detachable balloon group (P < 0.001). CONCLUSIONS: Embolisation of CCF with polyvinyl alcohol copolymer is as safe and effective as detachable balloon but has a much higher cost and longer operation time. KEY POINTS: • Carotid-cavernous fistula results from a damaged carotid artery. • Detachable balloons have been used with success for many years. • Some reported excellent outcomes after embolisation with polyvinyl alcohol copolymer. • Treatment expense is much higher in the polyvinyl alcohol copolymer group.
OBJECTIVES: To characterise the safety, efficacy and cost of direct carotid-cavernous fistula (CCF) treatment using polyvinyl alcohol copolymer or detachable balloons. METHODS: We reviewed retrospectively patients with direct CCFs treated with either a detachable balloon or polyvinyl alcohol copolymer at our hospital from 2005 to 2015 and identified 94 patients with 105 CCFs. All patients had follow-up angiograms. The CCF occlusion rate, procedure complication rate, treatment expense and operation time were recorded. RESULTS: With a mean of 5.4 months of angiographic follow-up, the complete occlusion rate and recanalisation rate of the polyvinyl alcohol copolymer group was not significantly different from that of the detachable balloon group. The treatment expense was much higher and the operation time was much longer in the polyvinyl alcohol copolymer group than the detachable balloon group (P < 0.001). CONCLUSIONS: Embolisation of CCF with polyvinyl alcohol copolymer is as safe and effective as detachable balloon but has a much higher cost and longer operation time. KEY POINTS: • Carotid-cavernous fistula results from a damaged carotid artery. • Detachable balloons have been used with success for many years. • Some reported excellent outcomes after embolisation with polyvinyl alcohol copolymer. • Treatment expense is much higher in the polyvinyl alcohol copolymer group.
Authors: Márcio C Pedro Marques; José Guilherme M Pereira Caldas; Dárcio R Nalli; Jose Roberto F Fonseca; Roberto G Nogueira; Nitamar Abdala Journal: Neuroradiology Date: 2010-05-12 Impact factor: 2.804
Authors: C E Baccin; C M S Campos; R Abicalaf; L H T Kanashiro; M R Bolcato; S S Lima; R L Piske Journal: Interv Neuroradiol Date: 2006-02-10 Impact factor: 1.610
Authors: Arun K Gupta; Sukalyan Purkayastha; T Krishnamoorthy; Narendra K Bodhey; T R Kapilamoorthy; C Kesavadas; Bejoy Thomas Journal: Neuroradiology Date: 2006-09-13 Impact factor: 2.804
Authors: Sean M Barber; Leonardo Rangel-Castilla; Y Jonathan Zhang; Richard Klucznik; Orlando Diaz Journal: J Neurointerv Surg Date: 2014-08-18 Impact factor: 5.836